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We have previously described (1) a mouse IgG3 monoclonal antibody (AbR24) with 
a  high  degree  of  serological  specificity  for  cultured  human  melanoma  cells.  All 
melanoma cell lines and two astrocytomas examined were positive for the heat-stable 
cell surface antigen detected by this antibody. Although choroidal melanocytes and 
brain had  low levels of the  antigen, a  wide  variety of other cells and tissues were 
unreactive. Three other monoclonal antibodies (Abs C5, I24, and K9), having a similar 
restricted specificity, were derived from the same fusion. These antibodies showed the 
same strong reactivity with melanomas and lack of reactivity with epithelial cells, but 
had a  slightly wider specificity range in that they also reacted weakly with MOLT-4 
(a T  cell line), leukocytes, and some fetal tissues. 
In  this  communication, we  identify  the  antigen  detected  by  AbR24  as  GD3, a 
previously  characterized  disialoganglioside.  1  In  comparison  with  other  cells  and 
tissues, melanomas have high levels of GD3. 
Materials and Methods 
Tissue Culture.  For derivations and culture of melanoma and other cells see refs. 1-4. Normal 
and malignant human tissue was obtained from surgical or postmortem specimens. 
Monoclonal  Antibodies.  Mouse monoclonal antibodies AbR24, AbCn, AbI12, and AbN9 have 
been previously described (1). AbR2a and AbC5 are IgG3 antibodies and AbI12 and AbN9 are 
IgG2b and IgG1 antibodies, respectively. 
Glycolipids.  GD3 was a  generous gift of Dr. Y.-T. Li, Tulane University, New Orleans (5). 
GM3 and GM2 were kindly provided by Dr. S. Kundu and Dr. D. M. Marcus, Baylor University, 
Houston, TX.  GMa, GDla, GT1 were purchased  from Supelco Inc., Bellefonte, PA.  Lactosyl- 
ceramide was purchased from Glycolipid Biochemical Co., Birmingham, AL. 
Serological Assays for Melanoma  Cell Surface Antigens.  Reactivity of AbR24 and AbC5 with cell 
surface antigens of melanoma cells was determined with cultured cells growing in the wells of 
Microtest plates (Falcon 3034,  Falcon Labware, Oxnard, CA) using an erythrocyte rosetting 
method (3)  in which indicator cells are human O  erythrocytes (RBC)  to which Staphylococcus 
* Supported by grants CA-08748, CA-21445, and CA-19765 from the U. S. Public Health Service, and 
by the Oliver S. and Jennie R. Donaldson Charitable Trust. 
l Abbreviations used in this paper."  C-M: chloroform-methanol; FBS: fetal bovine serum; PBS, phosphate- 
buffered saline; PA-MHA: protein A mixed hemagglutination assay; NANA: N-acetylneuraminic acid; 
TLC:  thin-layer chromatography; GG, gamma globulin; Gal: D-galactose; GIc: D-glucose; GalNAc: N- 
acetyl-D-galactosamine;  Cer: eeramide; GM1: flGal 1 ---* 3 GalNAc 1 ---* 4 flGal[3 <-- 2 NANA] 1 --* 4 GIc- 
Cer; GM3: NANA 2 -~ 3 flGal 1  ~  4 GIc-Cer;  GD3: NANA 2 ~  8 NANA 2 ~  3 flGal 1  ---* 4 GIc-Cer;  GDI,: 
NANA 2 ---* 3 flGal 1 ---, 3 GaINAe fl 1 ~  4 Gal [3 *---  2 NANA] Glc-Cer; GM2: flGalNAc 1 ---* 4 flGal [3 
2 NANA] Glc-Cer. GT1,: NANA 2 ---* 8 NANA 2 ~  3 flGal I --, 3 GalNAc fll ~  4 Gal [3 *---  2 NANA] 
Glc-Cer. (Nomenclature of Svennerholm, L.  1963. Chromatographic separation of human brain ganglio- 
sides.J. Neurochem. 10:613). 
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aureus protein A is conjugated (PA-MHA). AbI12 and AbN9 were assayed using a modification 
of this method in which rabbit anti-mouse Ig-conjugated indicator cells were used (IgG-MHA). 
Enzyme Treatment.  Melanoma cells growing as monolayers in microtest plates as described 
above were washed  with  Hanks' balanced salt  solution (HBSS,  Microbiological Associates, 
Walkersville, MD)  and then treated with  Vibrio cholerae neuraminidase (Calbiochem-Behring 
Corp., La Jolla, CA) or fl-galactosidase (Type VII; Sigma Chemical Co., St. Louis, MO) using 
1 U/well in 10/xl of HBSS. After incubation for  1 h at 37°C, the cells were washed four times 
with phosphate-buffered saline (PBS)-2% gamma globulin (GG)-free fetal bovine serum (FBS) 
and assayed for reactivity with antibody using the PA- or IgG-MHA assays. 
Isolation of Glycolipids.  Glycolipids were isolated initially by a modification of the method of 
Saito and Hakomori (6), and separated into neutral and acidic fractions by DEAE-Sephadex 
chromatography (7). Acidic glycolipids (gangliosides)  were subsequently isolated directly from 
chloroform-methanol (C/M)  extracts by DEAE-Sephadex chromatography and alkaline hy- 
drolysis (7). In brief, cells were homogenized in C/M (2:1) and after filtration were re-extracted 
with C/M  (1:1).  After evaporating and redissolving the extract  in C/M  (1:2),  it is filtered, 
evaporated, and dialyzed against distilled ice water for 24 h in the cold. After dialysis, samples 
were evaporated, dissolved  in C-M/HsO (30:60:8),  and applied to a DEAE-Sephadex column 
(equilibrated with C-M/0.8 M  Na acetate)  (30:60:8).  After washing the column with C/M/ 
HsO (30:60:8),  acidic lipids were eluted with C/M/0.8 M  Na acetate (30:60:8),  evaporated, 
and dialyzed as before. The acidic fraction was then hydrolyzed with 0.1 N NaOH in methanol 
for 3 h at 37°C, dialyzed against cold water (48 h), evaporated, and dissolved in C/M (4:1). 
The solution was applied to a  Biosil A column that had previously been washed with C/M 
(4:1). After eluting impurities with C/M (4:1), gangliosides were eluted with C/M (1:2). 
Thin-layer Chromatography (TLC).  Silica gel plates (Rediplates, Fisher Scientific Co., Pitts- 
burgh,  PA)  were  activated  by  heating  at  120°C  for  1  h.  Solvents  used  for  developing 
chromatograms were N-propanol/NH4OH/HsO,  60:9.5:11.5  (solvent 1)  (8)  and C/M/2.5 N 
NH4OH, 60:40:9 (solvent  2). Once the solvent had migrated 12 cm from the origin, the plate 
was  removed and air dried for  12-15 min at  110-120°C, cooled to room temperature, and 
sprayed with resorcinol-HC1  (9). For preparative analysis, plates were dried at room temperature 
in an air flow hood for 2-3 h. Bands were visualized with iodine vapor, outlined, and silica gel 
scraped from the plate. The gel was then extracted twice with 40 ml of C/M/Hs0 (50:50:15) 
with a small amount of Dowex  50 (Na+). The suspension was centrifuged at  1,000 rpm for  15 
rain, and the solution filtered, evaporated, redissolved in C/M (4:1), and applied to a Biosil A 
column as described above. Impurities were eluted with C/M (4:1), and adsorbed gangliosides 
were then eluted with C/M (1:2). 
Carbohydrate Analysis.  Lipid-bound sialic acid in cell pellets was determined on C/M  (2:1 
and 1:2) extracts after hydrolysis in 0.1 N  HCI at 80°C for  1 h as described by Warren (10). 
Sugars were analyzed after methanolysis (methanolic 1.0 N HCI at 100°C for 16 h) as their O- 
trifluoroacetates  (11);  N-acetylneuraminic acid was  identified by the  same procedure after 
methanolysis in 1.0 N HCI at 80°C for  1 h. 
Serological Assays for Glycolipids 
PASSIVE rtEMMAGLUTINATION  ASSAY (12).  Glycolipids (6 p.g sialic acid) were dissolved,  all- 
quoted into tubes (I0 X 75 mm), and dried in a dessicator with PsO5 in vacuo. To each tube, 200 
#1 of PBS was added, the sides of the tube scraped, and the solutions sonicated for  15 rain at 
50°C. After transfer to a larger tube, 0.8  ml of PBS was added. The glycolipid solution was 
added slowly in a dropwise fashion to a 2% suspension of human O-RBC in PBS. After 1 h at 
37°C with one mixing after 30 min, the cells were washed twice with PBS (12 ml each wash). 
Reactivity was tested by mixing a suspension of the treated RBC, and appropriately diluted 
AbR24 (50/~1 each)  in microtiter plates. After 1-2 h  at 4°C, the agglutination reactions were 
scored visually. 
ANTmODY INrtImTION ASSAY.  Glycolipids (6 #g sialic acid),  dissolved  in C-M  (1:2),  were 
aliquoted into tubes (6 X 50 ram) and dried as in the previous assay. AbR24 (1 ×  104 to 2 ×  104) 
was added (30 #1), and the tubes were vortexed and incubated for 30 rain at room temperature 
and  then  for  30  min at  4°C.  Tubes were  centrifuged for  20  rain  at  2,000  rpm,  and  the 
supernatants removed and serially diluted. These samples were  immediately transferred to 
formaldehyde-fixed SK-MEL-28 target cells.  (The formaldehyde fixation was carried out by PUKEL ET AL.  1135 
treating cells growing in the wells of microtest plates [Falcon 3034] with 0.33% HCHO in PBS. 
This treatment does not alter reactivity with AbR24 and provides a  store of readily available 
target cells). Antibody reactivity was detected with the PA-MHA assay. Unabsorbed antibody 
served as a positive control. 
GLYCOLIPID-MEDIATED IMMUNE ADHERENCE ASSAY (GMIA),  A  solution of glycolipids in 95% 
ethanol was added to the wells of microtest plates (Falcon 3034;  10 p,l per well) and the plates 
were dried in a dessicator in vacuo with P2Os for 45 min. Approximately 100 ng of lipid-bound 
sialic acid was found to be the optimal amount for efficient adsorption and maximal reactivity 
with antibody. Wells were then washed three times with PBS-2% GG-free FBS (10 ml/wash), 
and the plates were blotted with gauze. Diluted antibody (in PBS with 5% GG-free FBS) was 
added to the wells and incubated for 45 min at room temperature. Plates were blotted, washed 
four times with PBS-2% GG-free FBS, and blotted again. 10 #1 of a 0.2% suspension of protein 
A-conjugated O-RBC were added to the wells. The plates were incubated for 30 min at room 
temperature. After blotting, the plates were washed twice with PBS-2% GG-free FBS, blotted 
once  again,  and  read  under  the  light  microscope.  Reactions  were  scored  according  to  the 
proportion of the well covered  by RBC.  A  test was read as negative when wells showed  no 
adhering cells or only a  thin ring of cells around the perimeter. 
DETECTION OF SEROLOGICALLY-REACTIVE  GLYCOLIPID AFTER SEPARATION BY TLC.  Serological 
reactivity of glycolipids separated by TLC was tested using a  modification of the method of 
Magnani et  al.  (13)  in which  12~I-protein  A  was  used  to  detect  the  bound antibody. After 
chromatography in solvents 1 or 2, thin-layer sheets were washed in PBS buffer containing 1% 
polyvinylpyrolidone and treated with AbR24 (1:1,500)  for 6 h  at 4°C. After washing in PBS, 
the plate was treated with 125I-protein A  (10 #Ci/#g; 7 ×  105 cpm/ml) prepared according to 
the procedure of Hunter and Greenwood  (14).  After standing for  12 h  at 4°C, the plate was 
washed  in PBS, air-dried, and exposed to X-Omat R  film (Eastman Kodak Co.,  Rochester, 
NY) with a Cronex intensifier screen (Dupont Instruments, Wilmington, DE) for 2-6 hours. 
Results 
Alteration of AbR24  Serological  Reactivity and Kinetics of Antigen Restitution after Neuramin- 
idase  Treatment of SK-MEL-28.  After treatment with neuraminidase  ( Vibrio cholerae), 
SK-MEL-28 melanoma cells no longer reacted with AbR24 in PA-MHA  assays (Table 
I). Reactivity with AbC5 (an antibody with a  serological specificity similar to that of 
AbR24 [1]) was also lost. Reactivity with AbN9 and AbI12, which recognize serologically 
unrelated  determinants  on  glycoproteins  of SK-MEL-28,  was  unaffected  by  neur- 
aminidase.  Enzyme-treated  cells  did  not  show  nonspecific  reactivity  with  either 
protein A- or anti-mouse Ig-indicator cells, fl-Galactosidase had no detectable effect 
on the  reactivity of SK-MEL-28  cells with  AbR24 or AbC6  (Table I).  These  results 
TABLE  I 
Effect of Neuraminidase and fl-Galactosidase on the Reactivity of Monoclonal Antibodies with SK-MEL-28 
Melanoma Cells 
Neuramini-  fl-Galactosid-  Antibody*  IgG class*  Heatantigens,Sensitivity  of  Untreated:~  dase treated:~  ase treated~: 
Percent positive cells 
R~4  IgG3  Stable  100  <10  100 
C5  IgG3  Stable  100  < 10  100 
Na  IgGl  Sensitive  100  100  100 
I12  lgG2b  Sensitive  100  100  100 
* From Dippold et al.  (1). AbNa precipitates  a glycoprotein  antigen with a molecular weight  of 150,000 
and AbIl~ precipitates  a glycoprotein  antigen with a molecular weight of 95,000. 
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Ft6.  I.  Time course for the re-expression of AbR24-reactive antigen  on  SK-MEL-28 cells after 
neuraminidase  treatment.  Assay: PA-MHA. 
FIG. 2.  Localization of AbR24-reactive glycolipid on thin layer chromatograms  using glycolipid- 
mediated immune adherence  (GMIA) assay. Acidic glycolipids from SK-MEL-28 cells were sepa- 
rated by TLC in solvent I. Silica gel bands (1 cm wide) were scraped from the plate, extracted with 
C-M (1.2), and assayed for antigens by GMIA as described in the text. 
show  that  sialic  acid  constitutes  an  important  part  of the  antigenic  determinant 
recognized by antibodies AbR24 and AbCs. 
Serological reactivity of AbR24 with SK-MEL-28 remained undetectable for 30 min 
after  neuraminidase  was  removed  and  replaced  with  minimal  essential  medium 
(MEM)-FBS.  Continued  incubation  in  this  medium  at  37°C  resulted  in  a  partial 
return  of AbR24  reactivity after 2  h  and  complete recovery of serological reactivity 
after 22 h  (Fig.  1). 
Isolation  of AbR~-reactive Antigen from  SK-MEL-28 Melanoma Cells  and Its Identification 
as  Gm  Ganglioside.  Glycolipids were  isolated  from  cultured  melanoma  cells  (SK- 
MEL-28) by C-M extraction and Florisil chromatography of their acetates as described 
by  Saito  and  Hakomori  (6),  and  the  glycolipid preparation  was  fractionated  into 
neutral  and  acidic  components  by  DEAE-Sephadex  chromatography.  Inhibitory 
activity against AbR24 antibody (assayed with PA-MHA) was found to reside entirely 
in the acidic glycolipid fractions. 
In subsequent experiments, acidic glycolipids from SK-MEL-28 cells were isolated 
directly by  fractionating  the  C-M  extract  on  DEAE-Sephadex  (6)  and  eliminating 
contaminating  phospholipids by alkaline hydrolysis. Individual gangliosides in  this PUKEL  ET  AL.  1137 
FIG.  3.  TLC of acidic glycolipid fractions from a number of cell lines and tissues. Lane 1, GM3; 2, 
GD3; 3, GMI; 4, SK-MEL-28 melanoma cell line; 5, AbRz4-reactive antigen isolated from SK-MEL- 
28; 6, SK-MELo37 melanoma cell line; 7, SK-MEL-64 melanoma cell line; 8, MeW melanoma cell 
line;  9, SK-MEL-13 melanoma cell line;  10,  melanoma (surgical specimen);  11,  MOLT-4 T  cell 
line;  12, mouse eye;  13, SK-RC-7 renal cancer cell line;  14, adult human brain. Gangliosides were 
separated in solvent l and visualized with resorcinol-HC1. 
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Fxo.  4.  Densiometric tracings of thin layer chromatograms of gangliosides from melanomas and 
other cells. A, SK-MEL-28 melanoma cell line; B, SK-MEL-37 melanoma cell line; C, SK-MEL- 13 
melanoma cell line; D, melanoma (surgical specimen); E, adult human brain; F, Raji B cell line; G, 
MOLT-4 T  cell line; H, SK-RC-7 renal cancer cell line. The amount of GDs, as percentage of total 
ganglioside fraction, was calculated from the areas of the peaks and is indicated in each panel. 1 138  GDa  GANGLIOSIDE IN  HUMAN  MELANOMA 
TABLE  II 
Reactivity of AbR24 with gangliosides isolated from various cell lines and tissues as determined by 
four serological test systems* 
Passive  Inhibi-  J2~I-PA 
Source of gangliosides  hemagglu-  tion§  GMIAI[  TLC¶ 
tinin:]: 
Melanoma (surgical specimens) 
MEL-MU 
MEL-JI 
MEL-LO 
Melanoma cell lines 
SK-MEL- 13 
SK-MEL-21 
SK-MEL-28 
SK-MEL-31 
SK-MEL-37 
SK-MEL-64 
SK-MEL-93 
MeWo 
Carcinoma cell lines 
Renal 
SK-RC-7 
SK-RC- 11 
Bladder 
253J 
T-24 
RT-4 
Lung 
SK-LC-LL 
Cervix 
ME- 180 
Colon 
HT-29 
Other cells and tissues 
Astrocytoma cell lines 
AJ 
AS 
MOLT-4 (leukemia cell  line) 
Raji  (lymphoma cell line) 
Brain 
Bovine 
Mouse 
Fish 
ttuman (adult) 
Human (fetal  10-wk) 
Human (fetal  12- and 22-wk) 
Choroid (bovine) 
Eye 
Mouse 
Fish 
Liver 
Mouse 
ttuman (fetal) 
Human (adult) 
4-  4-  4-  4- 
4-  4-  4-  4- 
4-  4-  4- 
+  + 
4-  + 
4-  4-  4-  4- 
4-  4- 
4-  +  + 
4- 
4-  + 
4-  4-  +  + 
D 
--  4- 
+ 
+  + 
--  + 
+ 
4- 
4- 
+ 
4- 
4- 
_  _  4- 
--  --  + 
__  --  4- 
4-  4- 
--  --  4- 
+  + 
+  +  + 
--  --  4- 
4- PUKEL  ET  AL. 
TABLE  II--Continued 
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Passive  Inhibi-  J2SI-PA  Source of gangliosides  hemagglu-  tion§  GMIA]I 
tinin$  TLC¶ 
Spleen 
Mouse 
Human (fetal) 
Human (adult) 
Muscle (fetal human) 
Kidney 
Mouse 
Human (adult) 
Heart (mouse) 
Thymus (mouse) 
Lung 
Mouse 
Human (fetal or adult) 
Umbilicus 
Erythrocytes 
Human (A & B) 
Human (O) 
Horse 
Sheep 
Cat 
Placenta (human) 
Gangliosides 
R24-reactive glycolipid 
GD3 
GM1 
GM2 
GMZ 
GDIa 
GTI 
w 
--  + 
+  + 
--  +  +  + 
+ 
+ 
--  + 
--  --  --  -1- 
+  +  +  + 
+  + 
* Cells and tissues are human in origin unless indicated. 
$ Passive hemagglutination with glycolipid-coated RBC. AbR24 was used at a dilution of 1:100; a 
minimum of 5 #g of GDa could be detected. 
§ Inhibition of PA-MHA reactivity of Rz4 antibody (1:80,000) with SK-MEL-28 target cells. Results 
were scored  positive (+)  when  the degree of rosetting was  reduced  to <20%.  At  this  dilution, 
AhR24 could be completely inhibited by 2 #g of GD~. 
fl A reaction was considered positive when >50% of the surface  area of the well was covered by a 
lawn of protein A-conjugated RBC. AbR~4 was used at a dilution of 1:1000. With this amount of 
antibody, -25 ng of GD3 could be detected. 
¶ ~2~I-PA-TLC. In this procedure 6 ~tg of lipid-bound NANA was separated by TLC, and the plate 
treated with AbR24 (1:1500) and  12SI-protein A. Reactive components were detected by autora- 
diography. This procedure can detect ~ 10-25 ng of GDa. 
mixture  were  isolated  by  preparative  TLC  in  solvent  1  (8).  By  scraping  a  series  of 
silica gel bands  from the plates  and  extracting  the  glycolipids, the antigenic  activity 
was  located  in  the  major  acidic  glycolipid  band  that  migrated just  above  GMX  and 
GDaa  (Fig.  2).  In  the  data  presented  in  Fig.  2,  the antigenic  activity of fractions  was 
measured  by  the  GMIA  assay.  Similar results  were obtained  by antibody  inhibition 
tests using the PA-MHA  assay with AbR24 and  SK-MEL-28  target  cells. 
The  isolated  AbRz4-reactive  glycolipid  was  identified  as  NANA(2  ~  8)NANA Gn3 GANGLIOSIDE IN HUMAN MELANOMA  1140 
(2 --*  3)Gal/~(1 ~  4)Glc-ceramide (GDs) by the following criteria:  (a)  carbohydrate 
analysis of the purified glycolipid showed that it contained glucose, galactose, and N- 
acetylneuraminic acid  (NANA)  in a  ratio of 1.0:1.09:2.11,  with only a  trace (< 0.1) 
of hexosamine;  (b) partial hydrolysis of the ganglioside with  Vibrio cholerae neuramin- 
idase (3 h at 37°C) resulted in the formation of two components comigrating on thin- 
layer  chromatograms  with  GMs  and  lactosylceramide;  (c)  the  purified  melanoma 
glycolipid co-migrated with authentic  GD3 in TLC (Fig.  3);  and  (d)  AbR~4 reacted 
with authentic GDS, but  not with any of the other standard  gangliosides tested  (see 
below). 
Distribution of GDa in Melanoma and Nonmelanoma Cell Lines and in Normal and Malignant 
Tissues 
TLC PATTERNS OF GANGLIOSIDES FROM VARIOUS SOURCES.  Total ganglioside fractions 
were  prepared  from  a  large  variety of tumor  cell  lines,  fresh  tumors,  and  normal 
tissues. When these extracts were fractionated by TLC and the gangliosides detected 
using the resorcinol reagent, it became evident that melanomas have a characteristic 
pattern  of gangliosides.  In  all  the  melanoma  cell  lines  examined,  glycolipids  co- 
migrating with GDS and GM3 were prominent acidic glycolipids, with GD3 being the 
major component in many of these cell lines (Figs. 3 and 4). GD3 was also a prominent 
ganglioside  in  extracts  of mouse  eye  and  bovine  choroid.  With  the  exception  of 
MOLT-4  (a T  cell  line),  none  of the  other  cells  or  tissues  had  GDS  as  the  major 
component. Extracts of fresh melanoma tumors gave ganglioside patterns resembling 
SK-MEL-28, with GDS and GMs predominating  (Fig.  3).  Most  melanoma cell lines 
gave this simplified pattern, but some showed a more complex profile in which higher 
gangiiosides were detected  in appreciable amounts  (Figs.  3 and 4).  GDa constituted 
18-63% of the total ganglioside fraction in the melanoma cell lines examined (Fig. 4). 
Most  melanoma  cell  lines  and  specimens  had  values  in  the  30-50%  range.  These 
values compared with  7% in adult human brain, 9% in a  renal cancer cell line (SK- 
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FIG. 5.  Inhibition  of reactivity of AbR24 with SK-MEL-28 melanoma cells by acidic glycolipid 
fractions from a variety of cell lines and tissues. Assay: PA-MHA.  c~, AbR24 control;  ~, adult 
human spleen; 0, adult human liver; O, teleost eye; m, SK-RC-7 renal cancer cell line; A, adult 
human brain; O, MeWo melanoma cell line; ~>, SK-MEL-29 melanoma cell line; ~7, SK-MEL-37 
melanoma cell line; V, mouse eye; V'l, MOLT-4 T cell line; &, melanoma (surgical specimen); ~, 
SK-MEL-28 melanoma cell line. PUKEL  ET  AL.  1141 
Fro. 6.  GMIA assay using AbRz4. (A) AbR24-reactive  glycolipid isolated from SK-MEL-28 mela- 
noma cell line;  (B) Go3 ganglioside;  (C)  no ganglioside;  (D) GM2 and G~o ganglioside mixture. 
Antibody: AbR24 (1:1000).  )00 
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Fro.  7.  Detection ofGDa ganglioside by AbR24 in GMIA assays. AbR~4 dilutions are indicated in 
the figure. 
RC-7),  11% in RAJI cells (a Burkitt's lymphoma), and 33% in MOLT-4 cells (Fig. 4). 
In terms of the serological reactivity of AhR~, it is important to note that melanomas; 
in addition to having higher proportions of Gm in their glycolipid fraction, also have 
higher total ganglioside levels. This is evident  from a  determination of the levels of 1142  Gx~3 GANGLIOSIDE IN HUMAN  MELANOMA 
Fxo. 8.  Detection of GDa ganglioside on TLC plates by reactivity with AbR24 and ~251-protein A. 
Right side: gangliosides visualized with resorcinol-HCl reagent; left side: gangliosides reacting with 
AbR24 and  125I-protein A. Lane  1:  AbR2a-reactive ganglioside from SK-MEL-28; 2:  gangliosides 
extracted from adult human brain. Solvent 2. 
lipid-bound  sialic  acid  in  a  number  of cell  lines.  In  melanomas,  the  values  ranged 
from  0.039  to 0.063/~mol/0.1  ml  cells  (determined  on  nine  lines).  RAJI,  MOLT-4, 
and renal cancer cells (three lines) had lipid-bound  sialic acid values of 0.011  +  0.003, 
0.013  "4- 0.006,  and 0.025  -  0.029 ~mol/0.1  ml cells, respectively. 
DETECTION  OF  GD3  IN  CELL  LINES  AND  TISSUES  USING  ABR24  ANTIBODY.  GDS  levels in 
a  large  variety  of cells  and  tissues  were  estimated  using  R24  antibody.  Four  assay 
methods were used:  (a)  passive hemagglutination,  (b)  antibody  inhibition,  (c)  a  new 
method,  GMIA,  devised  to  combine  the  simplicity  of the  MHA  method  with  the 
ability  of glycolipids  to  adsorb  to  plastic,  and  (d)  a  method  using  12~I-protein  A  to 
detect AbR24 reacting with GD3 on TLC chromatograms.  The sensitivity of the assays 
varies considerably;  the passive hemagglutination  assay is the least sensitive,  and the 
125I-PA  method  the most sensitive  (Table II). 
Using  the  least  sensitive  detection  method  (passive hemagglutination),  GD3 could 
be detected  in extracts of melanoma cell lines and  melanoma tissue, but  not  in other 
sources (Table II). More sensitive assays (inhibition of PA-MHA and GMIA methods) 
showed that GD3 was detectable  in a  wider range of cells (bovine choroid,  mouse eye, 
fetal  and  adult  human  lung,  RAJI  B-cell  line,  MOLT-4  T-cell  line,  RT-4  bladder 
cancer  cell  line,  and  AJ  astrocytoma  cell  line).  A  typical  inhibition  experiment  is 
presented  in  Fig.  5,  and  the  data  are  summarized  in  Table  II.  Using  the  GMIA 
method,  it was found  that  wells coated with R24-reactive  glycolipids  from melanoma PUKEL ET AL.  1143 
(Fig. 6A)  or authentic GDZ gave strongly positive reactions (Fig. 6B); some quanti- 
tative data on this reaction are shown in Fig. 7. Other purified glycolipids (GMa, GDI~, 
GM3, and GM2) were unreactive in this assay (Table II and Figure 6 D). AbR24 added 
alone was also unreactive (Figure 6 C). Application of this method to acidic glycolipids 
extracted from other cells gave approximately the same results as inhibition assays 
(Table  II).  In  contrast  to  the  restricted  distribution  of GD3  determined  by  these 
methods, the 125I-protein  A method detected GD3 in all the cells and tissues examined 
(Table II and Fig. 8). That the AbRz4-reactive component detected in these tissues 
and cells was in fact GD~ was indicated by its co-migration with authentic GD3 (in two 
solvent  systems),  and  by  the  finding  that  another  protein  A-binding  monoclonal 
antibody (AbI12), detecting an unrelated glycoprotein specificity, was unreactive. 
Discussion 
Mouse monoclonal antibody R24, which shows a high degree of  serological specificity 
for cell surface antigens of melanoma cells, recognizes a disialoganglioside, GD3. Past 
studies have shown that  antibodies to gangliosides have been difficult to raise (15). 
This  may have  to  do  with  the  fact  that  most  gangliosides  are  constituents  of the 
species  being  immunized,  and  also  because  in  situ  sialidase  activity  may  destroy 
ganglioside  immunogenicity  (16).  In  this  regard,  it  might  be  significant  that  the 
mouse from which  AbR2a  was  developed had  been  extensively immunized  over a 
period of 6 mo with melanoma cells (SK-MEL-28) having a  very high GD3 content. 
Two other monoclonal antibodies  recognizing gangliosides  have recently been  de- 
scribed  (17,  18).  One reacts specifically with chicken neuronal cells and  is directed 
against  one of the higher gangliosides present in the GQ fraction (17); the second is 
directed against  human  colon carcinoma and  recognizes an as yet uncharacterized 
monosialoganglioside (18). 
In this report, we show that Go3 is a prominent ganglioside in cultured melanoma 
cells and in melanoma tissue. When compared with other cells, melanoma cells also 
possess relatively high total ganglioside levels. As shown by others, GIla is present in 
small amounts in most mammalian tissues, but it is a major ganglioside in the retina, 
where  it  comprises between  30  and  40% of the  gangliosides  (19).  In  adult  human 
brain, GD3 represents ~8-10% of the total ganglioside content (19). Levels of GD3 may 
be higher in fetal brain; in fetal rat brain (15-17 d gestation) GD3 represents -50% of 
the total ganglioside content, falling rapidly to -10% by day 20  (20).  Portoukalian 
and co-workers (21) have also reported that GD3, identified by TLC and carbohydrate 
analysis, is a  major constituent of melanomas. They showed that  the proportion of 
GD3  varied  from  31.0%  to  57.2%  of the  ganglioside  fraction in  the  four different 
melanoma specimens examined. From these results, as well as our own analysis, one 
can conclude that GD3 ganglioside is a prominent component of malignant melanoma. 
Whether normal melanocytes have high levels of GD3 is at present unclear. Normal 
choroidal  melanocytes show  weak reactivity with  AbR24  in  direct  serological tests 
(titer 1:100)  as compared with the strong reactivity of melanoma cells (titer of 1:5 × 
104 to  1:5  ×  105) (i).  With  the recent development of a  method for culturing skin 
melanocytes  (22),  it will  now be possible  to make a  direct comparison of the GD3 
content of melanocytes and  melanomas.  Although a  precise biological function for 
Go3 remains to be determined, it has been suggested that GDS has a role in serotonin 
binding (23, 24). 1144  GDa GANGLIOSIDE  IN  HUMAN  MELANOMA 
Ceramlde 
Glc-Cer 
Gal-Gle-Cer 
Gal-Glc-Cer 
[  CGM3) 
NANA 
./  "-. 
GalNAc-Gal-Glc-eer  Gal-Glc-Cer 
]  (gM2)  I  NANA 
NANA  ]  (GD3) 
NANA 
Gal-GalNAc-Gal-Glc-Cer  GalNAc-GaI-GIc-Cer 
{  (GMI)  {  NANA 
NANA  1  <GD2) 
NANA 
l  L 
Gal-GalNAc-Gal-Glc-Cer  Gal  -GalNAc-GaI-GI  c-Cer 
I 
{  {  (GDIa)  NANA 
NANA  NANA  1  (GD1  b  ) 
NANA 
Fro. 9.  Proposed pathways for the biosynthesis of gangliosides (modified after Yu  and Ando 
[26]). 
In examining the TLC patterns of the gangliosides isolated from different melanoma 
cell lines, we noticed considerable variation in the proportion of the various ganglio- 
sides. In most cell lines, GD3 and GMa were the predominant gangliosides (Figs. 3 and 
4).  A  few melanoma cell lines showed a  more complex pattern, with G~2 and some 
higher gangliosides being better represented; whether these differences in ganglioside 
profiles  correlate  with  biological  characteristics  (e.g.,  differentiation  state)  of the 
tumor needs to be determined. In general, melanomas exhibit a distinctive ganglioside 
profile. Of the other cells and tissues examined, only the T  cell line MOLT-4 showed 
a similar profile, and this may be another example of antigens shared by T  cells and 
cells of neuuroectodermal  origin, eg., Thy-1  (25).  Gangliosides derived  from bovine 
choroid and mouse eye had more complex patterns, with GDZ being only one of three 
or four prominent components. 
It  is  evident  from the  analysis  of extracted  glycolipids that  the  presence of GDa 
ganglioside is by no means restricted to melanoma cells--it is ubiquitous.  Yet using 
direct serological assays for cell surface antigens, only melanomas, choroidal melano- 
cytes, and astrocytomas were reactive with AbR24 (1). Even using sensitive absorption 
tests, only normal brain of other cells and tissues tested absorbed AbR2,. A  number 
of explanations for the apparent discrepancy between the serological finding and the 
biochemical data presented here can be suggested. First, it is possible that GD3 is not 
a  cell surface constituent  of most nonmelanoma cells. It is well established that Gm 
is  a  biosynthetic  precursor  of other  gangliosides  (Fig.  9)  and  would  therefore  be PUKEL  ET  AL.  1145 
located mainly within the cell, probably in the Golgi apparatus where the glycosyl 
transferases responsible for glycolipid synthesis are found (27, 28). As our biochemical 
studies were carried out on whole cells or tissues, the results are certainly compatible 
with this explanation. Another possibility is that GDa is present at the cell surface of 
R24-negative cells, but is not available for reaction with antibody. This phenomenon 
has  been  found  with  other  cell  membrane  glyeolipids,  e.g.,  globoside  is  a  major 
glycolipid of RBC membrane but RBC react only weakly with anti-globoside antibody 
(29).  It is also possible, of course, that  GD~ is  not expressed on the surface of most 
nonmelanoma cells in amounts that are detectable by the serological tests used. It is 
important  to note that  the cell types that  reacted with  AbR24  in  both  direct and 
absorption tests have both a high lipid-bound sialic acid content and have GD3 as a 
prominent ganglioside. 
What might be the mechanism of the accumulation of GD3 and GM3 in melanoma 
cells? One possible explanation is that melanoma cells have low levels of N-acetylga- 
lactosaminyl  transferase(s)  that  would  result  in  the  accumulation  of the  normal 
substrates for the enzyme(s), i.e., GMs and GD3 (Fig. 9). In bovine thyroid, a single N- 
acetylgalactosamine-transferase is thought to act on both GD3 and GM3 to form GD2 
and  GM2  (28),  and  low  levels  of this  enzyme  in  melanomas  could  explain  the 
ganglioside  pattern  we  observed.  Among  other  explanations,  it  is  possible  that 
melanomas  have  high  levels of fl-N-acetylgalactosaminidase  that  would  result  in 
increased degradation  of GM2 and  GD2, or that  melanomas  have elevated levels of 
certain  sialyltransferases,  resulting  in  increased  synthesis  of GD3  and  GMa.  It  is 
significant in this regard that melanoma patients have increased serum sialyltransfer- 
ase levels (30). Enzyme levels in tumor tissue have not yet been studied, although the 
fact that the glycoproteins of human melanoma cell lines have increased sialylation 
as compared with the glycoproteins of other cell types (31) suggests increased activity 
of this enzyme in melanoma. 
Summary 
Mouse  monoclonal antibody AbR24  has  a  high  degree of specificity for human 
melanoma  cells  when  tested  on  viable  cultured  cells  using  the  protein  A  mixed 
hemagglutinin  serological  assay.  The  antigen  detected  by this  antibody has  been 
isolated from melanoma cells and shown to be GD3 ganglioside by compositional and 
partial  structural  analysis  and  by  comparison  with  authentic  GDZ  in  thin  layer 
chromatography (TLC). AbR~  reacts with  authentic GDs, but  not  with any other 
ganglioside tested. Using TLC and reactivity with AbR~, a  wide range of cells and 
tissues  was  examined  for  the  presence  of GD3.  A  new  serological  assay,  termed 
glycolipid-mediated immune  adherence, was  devised for assaying  the  reactivity of 
AbR24 with gangliosides. Melanomas  (cultured cells or tumor tissue) were shown to 
have  GD3  and  G~8  as  major  gangliosides.  Other  cells  and  tissues  examined  also 
contained GD3, but usually only in low amounts. Melanomas (and MOLT-4, a T  cell 
line) were characterized by a simplified ganglioside profile with GD3 and GM3 as major 
components. The apparent discrepancy between the ubiquitous presence of GD3 and 
the serological specificity of AbR24  for melanoma cells can be explained in terms of 
localization and concentration of GD3 in different cells. 1146  GD3 GANGLIOSIDE IN  HUMAN  MELANOMA 
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